Clinical Trials Directory

Trials / Completed

CompletedNCT06140758

Evaluation of the Anticaries Efficacy of Dentifrice Formulations Using an In-situ Model

Evaluation of the Anticaries Efficacy of Various Dentifrice Formulations Using an In-situ Model

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Procter and Gamble · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

The primary objective is to compare the remineralization and demineralization inhibition potential of early subsurface carious lesions in enamel in situ after rinsing with six different aqueous slurries of toothpaste formulations.

Conditions

Interventions

TypeNameDescription
DRUGOral-B 1450 ppm Fluoride (1.16% sodium monofluorophosphate) DentifriceEach subject will use this product during one of the six treatment periods in the crossover study design.
DRUGColgate 1450 ppm Fluoride (1.16% sodium monofluorophosphate)DentifriceEach subject will use this product during one of the six treatment periods in the crossover study design.
DRUGToms of Maine 0 ppm Fluoride DentifriceEach subject will use this product during one of the six treatment periods in the crossover study design.
DRUGColgate 1450 ppm Fluoride (1.1% sodium monofluorophosphate) DentifriceEach subject will use this product during one of the six treatment periods in the crossover study design.
DRUG1500 ppm MFP/CaCO3 1.16% sodium monofluorophosphate) DentifriceEach subject will use this product during one of the six treatment periods in the crossover study design.
DRUG1100 ppm (0.454% Stannous fluoride) DentifriceEach subject will use this product during one of the six treatment periods in the crossover study design.

Timeline

Start date
2023-07-31
Primary completion
2023-12-11
Completion
2023-12-11
First posted
2023-11-20
Last updated
2024-02-29

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT06140758. Inclusion in this directory is not an endorsement.